biomarker discovery

AltraBio is a contract research company specializing in advanced biological data analysis and bioinformatics services, helping biopharma, cosmetic, and clinical R&D organizations extract insights from cytometry, omics, and medical data using AI, machine learning, and biostatistics. It serves pharmaceutical companies, biotech startups, dermo-cosmetic leaders, and university hospitals worldwide.

automated gatingbioinformatics pipeline developmentbiostatisticsbulk transcriptomicscytometry data analysishigh-dimensional panel analysismachine learningpatient stratificationproteomicsreal-world data miningsingle-cell RNA-seq analysisstatistical modelingtarget identification

Arima Genomics is building DNA-based cancer diagnostics that bring sequence and structure together to find more of what drives disease. Founded by leaders in 3D genome science, Arima applies Hi-C sequencing technology through Aventa clinical tests, biopharma partnerships, translational science, and platform innovation to advance a more complete DNA-based view of cancer.

3D genome scienceclinical cancer diagnosticsdetection of fusions and rearrangementsHi-C sequencing

Biodesix is a diagnostic solutions company that provides advanced diagnostic tests and custom development services. Its tests support clinical decisions for patients with lung disease, and its development services support biopharmaceutical, life sciences, and research institutions in developing diagnostic tests, tools, and therapeutics. The company operates two certified laboratories and uses its proprietary Diagnostic Cortex bioinformatics platform.

assay validationbioinformatics (Diagnostic Cortex platform)clinical trial sample testingcustom assay developmentddPCRgenomic testing and monitoringmulti-omics integrationNGSproteomic testingspatial proteomics with MALDI-IHCspecimen collection kit manufacturing

Biognosys is a proteomics company that invents and provides patented mass spectrometry-based proteomics solutions. It offers next-generation proteomics contract research services supporting pharma and biotech research and clinical development, along with proteomics software, peptide kits, and sample preparation reagents.

absolute protein quantificationContract Research Servicesdrug target identification and validationmass spectrometry-based proteomicsplasma proteomicsproteomics software development

BiomeSense is a microbiome data infrastructure company that developed an AI-enabled technology platform for reliable, longitudinal, and low-cost generation and analysis of microbiome data. Its platform combines novel hardware with AI-enabled bioinformatics to unlock the personalized medicine potential of the gut microbiome, partnering with scientists, institutions, and companies conducting clinical research.

AI-enabled bioinformaticscontinuous at-home microbiome trackinglaboratory servicesmicrobiome sequencingtime series analysis

Bio-PrecisionAI Health is an AI-driven biotech company that applies AI-guided discovery workflows to help research and biopharma teams move from biological insight to candidate design, biomarker discovery, and translational strategy. It integrates AI-guided design for small molecules, biologics, and oligonucleotides with biomarker discovery and scientific strategy. The company was founded on November 27, 2023 and incorporated in April 2024.

AI-guided small molecule designAI strategy consultingbioinformatics consultingbiologics and oligonucleotide discoverydata integrationgenomic and multi-omics data interpretationpredictive modelingworkflow design

Bioinformatics Solutions Inc. (BSI) is an AI-driven biotechnology company founded in Waterloo, Ontario in March 2000. BSI develops the PEAKS software for LC-MS/MS proteomics data analysis, used to identify and quantify proteins in complex biological samples, and offers lab services for antibody sequencing, ADC analysis, PTM and glycan profiling, and biomarker discovery.

ADC analysisantibody sequencingdatabase searchingde novo peptide sequencingDIA workflowglycoproteomics and glycomicsLC-MS/MS data analysismachine learning/AI algorithmsPTM analysis

CDI Labs provides proteomic products and services for autoantibody profiling, biomarker discovery, target identification, and antibody development. Its platforms include the HuProt™ Human Proteome Microarray (21,000+ full-length human proteins) and PhIP-Seq services such as HuScan®, MouseScan™, VirScan®, and VirScan® Exposome. The company also offers specialized CRO services including antibody development, protein production, cell therapy, and immunogenicity testing.

antibody developmentcell therapyCRISPR-Cas9 immunogenicity testingdiagnostic developmentimmunogenicity testingmolecular glue discoverypan-proteome epitope mappingPhIP-Seqpost-translational modification specificity profilingprotein microarrayprotein productionproteome-wide autoantibody profilingtarget identification

Circular Genomics is a precision neurology company focused on brain-derived circular RNA (circRNA) blood-based biomarkers. Its proprietary CircPath™ molecular intelligence platform translates circRNA signals into biological insights for neuroscience research, with an initial focus on Alzheimer's disease detection, prediction of symptom onset, and biomarker discovery. The company serves academic researchers, biopharma organizations, and Alzheimer's Disease Research Centers. For Research Use Only.

blood-based biomarker researchcircRNA profilingpathway-level analysiswhole-transcriptome circRNA sequencing

Decode Health is a precision medicine R&D company based in Nashville, TN. Its platform combines automated multiomics and clinical analytics with proprietary patient data and scientific expertise to accelerate biomarker discovery and clinical decision support for pharma, diagnostics, and health technology partners, producing validated findings in weeks rather than months.

automated data analyticsclinical decision supportclinical risk predictionmachine learningmultiomics analyticsRNA-seq

EnquBio Inc is a San Diego-based drug R&D technology and service company (preclinical CRO) that advances pharmaceutical and biotechnology research through a comprehensive suite of drug discovery solutions. Located in San Diego's biotech hub, it operates state-of-the-art facilities led by an industry-recognized team, offering expertise in exploratory biology, high-throughput screening, SAR studies, in vitro and in vivo pharmacology, immunology-focused studies, biomarker discovery, and clinical sample analysis.

assay developmentbioanalysiscell line generationex vivo pharmacologygene expression analysisgenome editinghigh content screeninghigh throughput screeningimmunoassayimmunophenotypingin vivo imagingin vivo pharmacologyiPSC platformnon-GLP toxicologyPK/PD analysisWestern blot

Etiome is a biotechnology company developing and deploying Biostaged Medicines, stage-specific therapies delivered to the right patient population at the right time. By building detailed models of molecular changes over the course of disease and applying single-cell omics and artificial intelligence, Etiome uncovers hidden patterns of disease progression to identify disease-modifying targets and biomarkers. Founded in 2021, originating from Flagship Pioneering's Preemptive Health and Medicine initiative.

artificial intelligencecomputational biologydrug discoverymachine learningsingle-cell omicstarget discovery

Foli Bio is building a molecular data layer for gut biology through stool-derived host RNA. Its Foli-seq™ platform profiles host RNA from naturally shed gut epithelial and immune cells to reveal mucosal inflammation, barrier function, disease biology, and therapeutic response, enabling non-invasive longitudinal transcriptomic readouts for translational studies, biomarker discovery, clinical diagnostics, and precision medicine.

assay developmenthost gut transcriptomicsNGS bioinformaticspatient stratificationpharmacodynamic monitoringstool-derived host RNA profiling

FYR Bio is a precision medicine company whose EV-Omics (EVO) platform uses AI-enabled multi-omic insights to profile extracellular vesicles (EVs) in blood, decoding RNA and protein signals to support biomarkers, clinical trials, diagnostics, and drug development. Its proprietary SPARCs technology enriches disease-associated EVs to improve signal-to-noise. The company partners on study design, custom data outputs, and clinical validation across diagnostics, drug development, and precision medicine.

AI-enabled multi-omic insightsCLIA laboratory testingclinical validationextracellular vesicle profilingliquid biopsyRNA and protein analysis